A comprehensive view of Gene Therapy & Regenerative Medicine. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Efforts are ongoing to rescue gene therapy for rare disease ADA-SCiD; researchers at UCL and UCLA are developing the non-FDA approved simoladagene autotemcel therapy, supported by nonprofits
Published: July 26, 2024 by MarketLine
European Commission approves Pfizer's DURVEQTIX® gene therapy for hemophilia B; reduces bleeds post-treatment with a median annualized bleed rate of zero bleeds after up to four years of follow-up
Published: July 25, 2024 by Pfizer Inc.
Pfizer advances hemophilia A gene therapy and honors cancer pharmacogenomics research; company also reduces greenhouse gas emissions in Spain and engages Greek pharmacy students for educational visit
Published: July 25, 2024 by Industry Intelligence Inc.
Thermo Fisher boosts cell and gene therapy with new workflow handbook and qPCR tools; company emphasizes efficient manufacturing to meet commercial market demands
Published: July 24, 2024 by Industry Intelligence Inc.
Pfizer announces positive Phase 3 results for hemophilia A gene therapy giroctocogene fitelparvovec; trial shows a significant reduction in mean total annualized bleeding rate
Published: July 24, 2024 by Pfizer Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count